Late relapse in acute myeloid leukemia (AML): clonal evolution or therapy-related leukemia? (Q60907709)

childhood acute myeloid leukemia

inferred from title

1 reference

Sanam Loghavi

3

0 references

Latasha Little

6

Latasha Little

0 references

Hagop Kantarjian

16

Hagop Kantarjian

0 references

Zeev Estrov

15

Zeev Estrov

0 references

Gautam Borthakur

10

Gautam Borthakur

0 references

Tapan Kadia

9

Tapan Kadia

0 references

Farhad Ravandi

19

Farhad Ravandi

0 references

Elias Jabbour

11

Elias Jabbour

0 references

Guillermo Garcia-Manero

14

Guillermo Garcia-Manero

0 references

P. Andrew Futreal

17

Andrew Futreal

0 references

Naveen Pemmaraju

12

Naveen Pemmaraju

0 references

Nicholas J. Short

13

Nicholas Short

0 references

Musa Yilmaz

1

Musa Yilmaz

0 references

Carlos B Bueso-Ramos

4

Carlos Bueso-Ramos

0 references

Curtis Gumbs

5

Curtis Gumbs

0 references

Koichi Takahashi

18

Koichi Takahashi

0 references

author name string

Feng Wang

2

0 references

Xingzhi Song

7

0 references

Jianhua Zhang

Creative Commons Attribution 4.0 International

8

0 references

language of work or name

English

0 references

publication date

16 January 2019

0 references

published in

Blood Cancer Journal

0 references

volume

9

0 references

issue

2

0 references

page(s)

7

0 references

copyright license

start time

16 January 2019

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Late relapses in acute myeloid leukemia: analysis of characteristics and outcome

1 reference

https://api.crossref.org/works/10.1038/S41408-019-0170-3

7 January 2021

Characteristics and outcomes of acute myelogenous leukemia patients with very late relapse (>5 years).

1 reference

https://api.crossref.org/works/10.1038/S41408-019-0170-3

7 January 2021

The characteristics and outcome of patients with late relapse acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038/S41408-019-0170-3

7 January 2021

Genetic pathways in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038/S41408-019-0170-3

7 January 2021

Clonal evolution of acute myeloid leukemia relapsed after 19 years of remission

1 reference

https://api.crossref.org/works/10.1038/S41408-019-0170-3

7 January 2021

Fast and accurate short read alignment with Burrows-Wheeler transform

1 reference

https://api.crossref.org/works/10.1038/S41408-019-0170-3

7 January 2021

Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples

1 reference

https://api.crossref.org/works/10.1038/S41408-019-0170-3

7 January 2021

Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads

1 reference

https://api.crossref.org/works/10.1038/S41408-019-0170-3

7 January 2021

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

1 reference

https://api.crossref.org/works/10.1038/S41408-019-0170-3

7 January 2021

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1038/S41408-019-0170-3

7 January 2021

Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing

1 reference

https://api.crossref.org/works/10.1038/S41408-019-0170-3

7 January 2021

Clonal Hematopoiesis and Evolution to Hematopoietic Malignancies

1 reference

https://api.crossref.org/works/10.1038/S41408-019-0170-3

7 January 2021

Epigenetic dysregulation of hematopoietic stem cells and preleukemic state

1 reference

https://api.crossref.org/works/10.1038/S41408-019-0170-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1038/S41408-019-0170-3

7 January 2021

Molecular Minimal Residual Disease in Acute Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1038/S41408-019-0170-3

7 January 2021

Mortality associated with influenza and respiratory syncytial virus in the United States

1 reference

https://api.crossref.org/works/10.1038/S41408-019-0170-3

7 January 2021

The impact of influenza on the health and health care utilisation of elderly people.

1 reference

https://api.crossref.org/works/10.1038/S41408-019-0170-3

7 January 2021

Better influenza vaccines for older people: what will it take?

1 reference

https://api.crossref.org/works/10.1038/S41408-019-0170-3

7 January 2021

Hallmark features of immunosenescence are absent in familial longevity

1 reference

https://api.crossref.org/works/10.1038/S41408-019-0170-3

7 January 2021

Cancer, aging and immunotherapy: lessons learned from animal models

1 reference

https://api.crossref.org/works/10.1038/S41408-019-0170-3

7 January 2021

Potential role of immunosenescence in cancer development

1 reference

https://api.crossref.org/works/10.1038/S41408-019-0170-3

7 January 2021

Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia.

1 reference

https://api.crossref.org/works/10.1038/S41408-019-0170-3

7 January 2021

Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038/S41408-019-0170-3

7 January 2021

Genetic variegation of clonal architecture and propagating cells in leukaemia

1 reference

https://api.crossref.org/works/10.1038/S41408-019-0170-3

7 January 2021

Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells.

1 reference

https://api.crossref.org/works/10.1038/S41408-019-0170-3

7 January 2021